Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple-Drug Therapy for Lymphatic Filariasis Elimination in PNG
NCT01975441Phase 2Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- May 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin in lymphatic filariasis (LF), sponsored by University Hospitals Cleveland Medical Center. Started May 2014; status: completed.
02
Drugs
ivermectin
03
Conditions
lymphatic filariasis (LF)
Beyond the preview
Go deeper on NCT01975441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975441.